Gut Microbiome Composition Varies in Atherosclerotic Cardiovascular Disease

NEW YORK (GenomeWeb) – The gut microbiomes of people with atherosclerotic cardiovascular disease differ greatly from those of healthy people, according to a new study.

Previous work has suggested that the gut microbiome may influence the development of atherosclerosis. Microbes in the gut metabolize choline, phosphatidylcholine, and L-carnitine to produce trimethylamine (TMA), which is transformed in the liver into trimethylamine-N-oxide (TMAO), a major cause of atherosclerosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?

Read more

Leave A Comment

Your email address will not be published. Required fields are marked *